Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 2;139(30):10196-10199.
doi: 10.1021/jacs.7b05196. Epub 2017 Jul 24.

Enantioselective Total Synthesis of Nigelladine A via Late-Stage C-H Oxidation Enabled by an Engineered P450 Enzyme

Affiliations

Enantioselective Total Synthesis of Nigelladine A via Late-Stage C-H Oxidation Enabled by an Engineered P450 Enzyme

Steven A Loskot et al. J Am Chem Soc. .

Abstract

An enantioselective total synthesis of the norditerpenoid alkaloid nigelladine A is described. Strategically, the synthesis relies on a late-stage C-H oxidation of an advanced intermediate. While traditional chemical methods failed to deliver the desired outcome, an engineered cytochrome P450 enzyme was employed to effect a chemo- and regioselective allylic C-H oxidation in the presence of four oxidizable positions. The enzyme variant was readily identified from a focused library of three enzymes, allowing for completion of the synthesis without the need for extensive screening.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structures of nigelladines A–C and nigel-laquinomine.
Figure 2
Figure 2
Retrosynthetic analysis of nigelladine A (1).
Scheme 1
Scheme 1
Synthesis of dienone 13
Scheme 2
Scheme 2
Condensation of imine 5
Scheme 3
Scheme 3
Completion of the synthesis of nigelladine Aa aADH, alcohol dehydrogenase; KPi, potassium phosphate; DMP, Dess-Martin periodinane.

References

    1. For recent reviews on direct C–H functionalization see: Lyons TW, Sanford MS. Chem Rev. 2010;110:1147–1169.Wencel-Delord J, Dröge T. Chem Soc Rev. 2011;40:4740–4761.Engle KM, Mei TS, Wasa M, Yu JQ. Acc Chem Res. 2012;45:788–802.Wendlandt AE, Suess AM, Stahl SS. Angew Chem, Int Ed Engl. 2011;50:11062–11087.Gutekunst WR, Baran PS. Chem Soc Rev. 2011;40:1976–1991.Yamaguchi J, Yamaguchi AD, Itami K. Angew Chem Int Ed Engl. 2012;51:8960–9009.Davies HML, Manning JR. Nature. 2008;451:417–424.

    1. Chen QB, Xin XL, Yang Y, Lee SS, Aisa HA. J Nat Prod. 2014;77:807–812. - PubMed
    2. Zhang S, Zhang ZY. Drug Discovery Today. 2007:373–381. - PubMed
    1. Nakamura A, Nakada M. Synthesis. 2013;45:1421–1451.
    1. Weidmann V, Maison W. Synthesis. 2013;45:2201–2221.
    1. For reviews of biocatalysis and directed evolution see: Arnold FH. Acc Chem Res. 1998;31:125–131.Reetz MT. Angew Chem, Int Ed Engl. 2001;40:284–310.Turner NJ. Nat Chem Biol. 2009;5:567–573.Wohlgemuth R. Curr Opin Biotechnol. 2010;21(6):713.Reetz MT. J Am Chem Soc. 2013;135:12480–12496.Nestl BM, Hammer SC, Nebel BA, Hauer B. Angew Chem, Int Ed Engl. 2014;53(12):3070.Denard CA, Ren H, Zhao H. Curr Opin Chem Biol. 2015;25:55–64.

Publication types

MeSH terms